Jeffrey Jonas

Jeffrey Jonas served as Chief Executive Officer of Sage Therapeutics from 2013 to 2020, where he engineered one of the industry’s leading product pipelines in brain health. Currently he is Sage’s Chief Innovation Officer a member of Sage’s Board and chair of the Science and Technology Forum of Sage’s Board. Prior to Sage, Dr. Jonas spent five years with Shire Pharmaceuticals as President of the Regenerative Medicine Division and previously as Senior Vice President of Research and Development Among his various achievements, Dr. Jonas expanded Shire’s lead therapy beyond its initial indication Before joining Shire, Dr. Jon a s served as Executive Vice President of ISIS Pharmaceuticals and held senior positions at Forest Laboratories and Upjohn Laboratories. H e received an undergraduate degree from Amherst College and a medical degree from Harvard Medical School.